Castle Biosciences Inc

Castle Biosciences Inc

CSTL

Market Cap$587.55M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Castle Biosciences IncCastle Biosciences Inc-114.9--1%1.70.1
$30.00

Target Price by Analysts

46.9% upsideCastle Biosciences Target Price DetailsTarget Price
$33.86

Current Fair Value

65.8% upside

Undervalued by 65.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$587.55 Million
Enterprise Value$523.71 Million
Dividend Yield$0 (0%)
Earnings per Share$0.66
Beta1.04
Outstanding Shares28,609,000

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio-114.85
PEG-12.48
Price to Sales1.7
Price to Book Ratio1.36
Enterprise Value to Revenue1.51
Enterprise Value to EBIT36.05
Enterprise Value to Net Income-104
Total Debt to Enterprise0.05
Debt to Equity0.06

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Castle Biosciences Inc